Human preprorenin was synthesized in Chinese hamster ovary (CHO) cells transfected with an expression vector containing renin cDNA sequences. These cells secrete an inactive form of renin (EC 3.4.23.15) that can be activated by trypsin. This inactive renin is precipitable by antibody generated against purified human renal renin and also by antisera generated to a synthetic peptide derived from the amino acid sequence of the pro segment of preprorenin (anti-propeptide), indicating that the secreted inactive enzyme is a form of prorenin. Analysis of [35S]methionine-labeled proteins immunoprecipitated from CHO cell conditioned culture medium indicates that prorenin is expressed in CHO cells as two distinct forms that differ in their degree of glycosylation. In vitro trypsin activation of prorenin cleaves approximately 4.5 kDa from the protein, rendering it unreactive with the antipropeptide antiserum but still recognizable by anti-renal renin antibody. These results show directly that the prorenin expressed by CHO cells is an inactive enzyme that is activated by trypsin cleavage of the pro segment. The ability to express human renin in this form will allow for the purification of both active and inactive forms of the enzyme in quantities sufficient for detailed physiological and structural studies.
The renin-angiotensin system plays a pivotal role in blood pressure homeostasis and in the regulation of extracellular fluid volume. Renin (EC 3.4.23.15 ) is an aspartyl protease that catalyzes the first and rate-limiting step in the sequence of reactions that leads to the production of the potent pressor substance angiotensin II (1) . Renin is found in highest concentration in kidney (2) from which it is secreted into the bloodstream; however, the enzyme has also been detected in several extrarenal tissues (3) . Additionally, human kidney, plasma, and amniotic fluid contain an inactive form of renin that can be activated by a variety of treatments, e.g., incubation with trypsin (4) . Although the inactive form is usually the predominant species in human plasma, accounting for up to 90% of the total renin (4), the molecular identity of inactive renin has been a matter of considerable dispute. Many biochemical and physiological questions relating to renin and prorenin remain unanswered, in part, due to the difficulty in obtaining the necessary quantities of these proteins in pure form.
Amino acid (5) and cDNA (6) sequence analyses of mouse submaxillary gland renin show that this enzyme is synthesized as a precursor, containing a proposed 18-amino acid amino-terminal signal sequence and a 45-amino acid pro segment followed by the active enzyme. cDNA (7) and genomic DNA sequence analyses (8) (9) (10) of human renin suggest that the human enzyme is also synthesized as preprorenin [with a 20-amino acid signal sequence and 46-amino acid pro segment (43) ]. It has often been suggested that plasma and tissue inactive renins may be prorenin (4, 11) , and this view is supported by experiments (12) (13) (14) showing that inactive renin from human plasma and kidney binds to antibodies raised against synthetic peptides corresponding to portions of the predicted pro segment of human prorenin (7) .
To examine directly the properties of prorenin as well as to investigate its posttranslational processing, we have constructed a plasmid designed to express human preprorenin in mammalian cells. We (15) that was cloned into the EcoRI site of the bacteriophage vector XgtlO (16) using EcoRI linkers. The library was screened with probes derived from the human renin gene (8) , and hybridizing cDNA inserts were sequenced (17) . These inserts were comprised ofhuman renin cDNA extending from base 8 of the protein coding region of the published sequence of Imai et al. (7) Fig. 1 ). The coding region is followed by the 3'-untranslated region including the polyadenylylation signal and a stretch of approximately 150 bases of poly(A). Plasmid pHR14 was cotransfected into CHO cells with pSV2neo (20) by the calcium phosphate precipitation method (21) . Aminoglycoside-resistant cells were selected by growth in G418 at 400 pug/ml (GIBCO (22) . Inactive renin was activated with trypsin at 50-100 ,ug/ml in activation buffer [50 mM Tris HCl (pH 8.0), 0.1 M NaCl, 3 mM EDTA, 10 mM benzamidine, and 0.5% bovine serum albumin (22) ]. Renin activity was measured as the rate of angiotensin I production in the presence of 0.3 uM human angiotensinogen. Angiotensin I was quantitated by radioimmunoassay (Travenol-Genentech Diagnostics).
Production of Antibodies. Anti-renin antiserum (R1723), obtained from a rabbit immunized with pure human renal renin (23, 24) , has a 50%o inhibitory titer of 1:30,000 against 1 X 10-4 Goldblatt units of standard human renal renin (National Institute for Biological Standards and Control, London). The antiserum is specific for renin as demonstrated by immunodiffusion and immunoelectrophoresis analysis, and it does not crossreact with cathepsins D or B, renal kallikrein, or pepsin (24) .
A rabbit antiserum (anti-propeptide) was generated against a 12-amino acid synthetic peptide corresponding to the carboxyl end of the putative pro segment of human prorenin (Arg-Leu-Gly-Pro-Glu-Trp-Ser-Gln-Pro-Met-Lys-Arg). The peptide, synthesized by solid-phase methods and purified (25, 26) (22) , were treated with trypsin (50-100 ,ug/ml) for 1 hr at room temperature and soybean trypsin inhibitor (100 ;kg/ml) for 10 min before immunoprecipitation.
Immunoprecipitation of Radiolabeled CHO-CM. s35-labeled CHO-CM was diluted 1:1 in activation buffer containing 0.05% Nonidet P-40 and 0.05% NaDodSO4. Antiserum was added to a final dilution of 1:300 and incubated at 40C for 3-18 hr. Immunoglobulin was precipitated with an excess of protein A-Sepharose (Pharmacia). Pellets were washed three times with 50 mM Tris HCl (pH 7.5), 0.15 M NaCl, 5 mM EDTA, 0.5% Nonidet P-40, ovalbumin at 1 mg/ml and once with the same buffer lacking ovalbumin. The final pellet was resuspended in gel sample buffer, electrophoresed through a NaDodSO4/10% polyacrylamide gel (27) , and fluorographed with Enlightning (New England Nuclear). Endoglycosidase F Digestion. 35S-labeled CHO-CM was adjusted with sodium phosphate, pH 6.5 (10 mM, final concentration) and EDTA (20 mM, final concentration) and incubated with endoglycosidase F (endo F) at 4 units/ml (New England Nuclear) for 12-18 hr at 37°C.
RESULTS
Renin Activity in Transfected CHO-CM. The expression plasmid pHR14 directs the synthesis of human preprorenin. This plasmid encodes a renin signal sequence modified at its amino terminus as compared to the natural signal sequence of human preprorenin; the putative signal peptidase cleavage site between amino acids 23 and 24, however, remains unchanged (Fig. 1) . CHO-CM from confluent cultures of CHO cells transfected with either pHR14 or a control plasmid was assayed for renin activity with or without trypsin activation using human angiotensinogen as substrate (Table  1) . Without trypsin activation, CHO-CM from pools of pHR14-transfected cells does contain detectable renin activity. However, following limited proteolysis with trypsin, under conditions that are known to activate human inactive renin (22) , renin activity in the CHO-CM increases over Diagram of the preprorenin expression plasmid pHR14. The cDNA coding for the signal sequence ("pre"), the propeptide ("pro") and mature renin ("renin") was cloned into plasmid pMTpro that contains the regulatory elements and the initiator methionine from the human metallothionein II gene. The cDNA contained a translation termination site (TGA), polyadenylylation signal (AATAAA) and poly(A) tail (A). As shown, the construction codes for a signal sequence ("expressed") that differs from the authentic renin signal sequence ("authentic") at its amino-terminus (7) . The dotted line indicates the location of the blunt ligation between the promoter fragment and the 5' end of the cDNA.
Biochemistry: Fritz et al. 25-fold. Control supernatants do not contain detectable renin activity either before or after trypsin activation. The expressed renin activity was further characterized by immunoprecipitation (Fig. 2) . Trypsin-activatable renin activity in CHO-CM is immunoprecipitable by both antipropeptide and anti-renin antisera (Fig. 2, Left) demonstrating that the enzyme is indeed a form of prorenin. If however, supernatants are treated with trypsin before antibody addition, only anti-renin but not anti-propeptide antiserum precipitates enzyme activity (Fig. 2, Right) . This demonstrates that trypsin activation of expressed prorenin generates active renin by cleavage of the propeptide.
To further compare the expressed renin activity to that of authentic renal renin, the relative sensitivity of these two renins to a renin inhibitor was assayed. Accordingly, we synthesized and purified (25, 26) renin inhibitory peptide Gly-Gly-His-Pro-Phe-His-Statine-Ile-Phe-NH2, a modification of a peptide described by Boger et al. (28) . Fig. 3 shows that this peptide inhibits recombinant renin activity with a dose-response relationship identical to that observed with human kidney renin.
These results indicate that CHO cells transfected with the expression plasmid pHR14 secrete inactive prorenin, which is activated by trypsin cleavage, yielding a protein with the immunological and enzymatic properties of active human kidney renin.
Immunoprecipitation ing autoradiograms (Fig. 4) demonstrate that CHO-CM from cells transfected with pHR14 contain two proteins of molecular sizes 50.2 ± 0.7 and 48.9 ± 0.7 kDa (n = 8), which are immunoprecipitable with either anti-propeptide or anti-renin antisera (Fig. 4, lanes 4 and 5) . Immunoprecipitation of trypsin-activated supernatants with anti-renin antiserum reveals two smaller proteins, 45.7 ± 0.6 and 44.2 ± 0.3 kDa (n = 3) (Fig. 4, lane 6) . Neither of these lower molecular size forms is precipitable by anti-propeptide antiserum (data not shown). Both the shift in size of the immunoprecipitable protein upon trypsin treatment and the loss of anti-propeptide reactivity are consistent with the complete removal of the putative 43-amino acid propeptide. The immunoprecipitable 4) or anti-human renin antiserum (lanes 2 and 5). Other supernatants were treated with trypsin at 100 pg/ml followed by soybean trypsin inhibitor (lanes 3 and 6) before immunoprecipitation with anti-renin antiserum. Both anti-propeptide and anti-renin antisera specifically immunoprecipitate two proteins (lanes 4 (Fig. 4, lanes  1-3) .
To investigate the possibility that the two distinct prorenin forms represent heterogeneous glycosylation, proteins immunoprecipitated from endo F-treated CHO-CM were compared to those immunoprecipitated from untreated CHO-CM. Endo F cleaves both complex and high-mannose Nlinked sugar chains leaving a single N-acetylglucosamine moiety attached to each glycosylated asparagine residue (29) . Whereas anti-propeptide antiserum immunoprecipitates two distinct protein species from untreated CHO-CM (Fig. 4, lane   4 and Fig. 5, lane 1) , endo F treatment results in only a single immunoprecipitable protein (Fig. 5, lane 3) . This protein migrates on NaDodSO4/polyacrylamide gels at a molecular size of44 kDa (n = 2) and has an identical mobility to prorenin expressed in bacteria (Fig. 5, lane 5) , which is not posttranslationally modified by glycosylation. (The expression of prorenin and renin in bacterial cells will be described elsewhere.) The specificity of the immune precipitations is shown by controls using preimmune serum (Fig. 5, lanes 2  and 4) . The expression of a unique prorenin polypeptide that exists in two glycosylated forms was further demonstrated by immunoprecipitation experiments using radiolabeled cultures grown in the presence of tunicamycin. Tunicamycin treatment, which inhibits the transfer of core sugars to peptide chains (30) , also results in the appearance ofa 44-kDa form of prorenin precipitable with anti-propeptide antiserum (data not shown). Interestingly, deglycosylation has no apparent effect on enzymatic activity. When samples of activated prorenin (5,000-10,000 ng of angiotensin per hr)
were treated with an excess of endo F, the deglycosylated material had an activity 106 ± 34% of the untreated glycosylated material (100 ± 21%) (n = 6). Furthermore, immunoprecipitation of [35S]methionine-labeled CHO-CM shows that the size of the secreted enzyme is consistent with the secretion of a prorenin molecule. These immunochemical properties indicate that the secreted protein is indeed a form of prorenin although an unambiguous identification of the amino terminus of the secreted product must await its purification and sequencing.
DISCUSSION
It has been reported that kidney and plasma inactive renins are recognized by antibodies directed against prosegment synthetic peptides (12) (13) (14) , providing strong evidence that these inactive renins are prorenin. Our result that expressed prorenin is an inactive but activatable form of renin supports this hypothesis.
In prorenin-containing CHO-CM we do detect a low level of renin activity in the absence of added trypsin (Table 1) . This may be due in part to a slow rate ofproteolytic activation of prorenin resulting from the presence in the medium of proteases that are normally secreted by CHO cells. In accord with this idea, the percentage of enzyme that is active in the absence of added trypsin increases with time upon storage of the supernatants at 40C (unpublished observations Following trypsin activation, the expressed renin activity is inhibitable by a statine-containing renin inhibitory peptide. The concentration dependence of this inhibitor is identical to that observed when it is tested against purified human renal renin (Fig. 3) , suggesting that the authentic and expressed enzymes are very similar. Furthermore, the reduction in apparent molecular size of approximately 4.5 kDa following trypsin activation (Fig. 4) and the fact that the anti-propeptide antiserum does not recognize the activated enzyme (Fig. 2) both argue that trypsin cleaves off the prosegment at the predicted site for in vivo processing, leucine-67 (7). This has now been directly confirmed by purification and aminoterminal sequencing of the trypsin-treated active (400-800 Goldblatt units/mg) enzyme (details of which will be pub- fTh ability to produce human renin and prorenin by repombinant DNA techniques will now petmit both a more detailed investigation of their physiological roles as well as thb isolation of large amounts of enzyme for x-ray crystaliographic analysis. Current three-dimensional models of human renin are based on x-ray data derived from other aspartyl proteases, together with the primary sequence of human renin (40) (41) (42) . It will be possible to, build more accurate models, useful for the rational design of renin inhibitors, from crystallographic data derived directly from the human enzyme and proenzyme.
